U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805343) titled 'Extended Validation of Donor-derived Cell-free DNA in Kidney Transplant Recipients' on Aug. 24.
Brief Summary: This is a multinational, multi-center, observational cohort study.
Kidney allograft rejection is poorly detected by standard-of-care biomarkers. Although dd-cfDNA has been associated with improved rejection detection when added to standard-of-care biomarkers and clinical parameters, little is known about its performance across Banff 2022 rejection phenotypes and injury patterns, in various clinical scenarios and populations, and when measured repeatedly over time.
Study Start Date: June 15, 2024
Study Type: OBSERVATIONAL...